Grifols, S.A. Company Profile (NASDAQ:GRFS)

About Grifols, S.A.

Grifols, S.A. logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GRFS
  • CUSIP:
Key Metrics:
  • Previous Close: $17.40
  • 50 Day Moving Average: $16.99
  • 200 Day Moving Average: $16.01
  • 52-Week Range: $14.27 - $17.51
  • Trailing P/E Ratio: 42.28
  • Foreward P/E Ratio: 16.18
  • P/E Growth: 1.21
  • Market Cap: $23.76B
  • Outstanding Shares: 1,365,648,000
  • Beta: 1.12
Profitability:
  • Net Margins: 13.40%
  • Return on Equity: 17.54%
  • Return on Assets: 6.26%
Debt:
  • Debt-to-Equity Ratio: 1.27%
  • Current Ratio: 3.19%
  • Quick Ratio: 1.52%
Additional Links:
Companies Related to Grifols, S.A.:

Analyst Ratings

Consensus Ratings for Grifols, S.A. (NASDAQ:GRFS) (?)
Ratings Breakdown: 1 Sell Rating, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: N/A

Analysts' Ratings History for Grifols, S.A. (NASDAQ:GRFS)
Show:
DateFirmActionRatingPrice TargetDetails
1/3/2017J P Morgan Chase & CoUpgradeNeutral -> OverweightView Rating Details
6/6/2016Morgan StanleyReiterated RatingSellView Rating Details
3/17/2016NomuraInitiated CoverageBuyView Rating Details
2/9/2016Berenberg BankUpgradeHold -> BuyView Rating Details
12/2/2015HSBC Holdings plcDowngradeBuy -> Hold$22.50View Rating Details
5/19/2015Goldman Sachs Group, Inc. (The)Reiterated RatingBuyView Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Grifols, S.A. (NASDAQ:GRFS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/12/2015$0.58$0.53ViewN/AView Earnings Details
11/18/2014$0.51$0.44ViewN/AView Earnings Details
8/15/2014$0.55$0.40ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Grifols, S.A. (NASDAQ:GRFS)
Current Year EPS Consensus Estimate: $0.96 EPS
Next Year EPS Consensus Estimate: $1.08 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.24$0.52$0.38
Q2 20162$0.26$0.55$0.41
Q3 20161$0.53$0.53$0.53
Q4 20161$0.26$0.26$0.26
Q1 20171$0.25$0.25$0.25
Q2 20171$0.26$0.26$0.26
Q3 20171$0.30$0.30$0.30
Q4 20171$0.29$0.29$0.29
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Grifols, S.A. (NASDAQ:GRFS)
Annual Dividend:$0.27
Dividend Yield:1.55%
Payout Ratio:28.13% (Based on Current Year Consensus EPS Estimate)
25.00% (Based on Next Year Consensus EPS Estimate)

Dividend History for Grifols, S.A. (NASDAQ:GRFS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/22/2016$0.1512/5/201612/7/201612/7/2016
5/31/2016$0.116/2/20166/6/20166/6/2016
12/1/2015$0.3012/10/201512/14/201512/14/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Grifols, S.A. (NASDAQ:GRFS)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Grifols, S.A. (NASDAQ:GRFS)
DateHeadline
realistinvestor.com logoResearch Analysts Set Grifols, SA (NASDAQ:GRFS) Price Target at $15 - RealistInvestor.com (NASDAQ:GRFS)
www.realistinvestor.com - February 11 at 10:39 PM
News IconTrading Views: Watching Shares of Grifols SA (GRFS) - Benton Bulletin (NASDAQ:GRFS)
bentonbulletin.com - February 9 at 6:21 PM
News IconChecking Indicator Levels for Grifols SA (GRFS) - Piedmont Register (NASDAQ:GRFS)
piedmontregister.com - February 7 at 11:49 PM
News IconCould Grifols SA, Barcelona (GRFS) See a Reversal After Breaking Its 52-Week High? (NASDAQ:GRFS)
randolphguide.com - February 3 at 6:01 PM
finance.yahoo.com logoHologic Completes Divestiture of Blood Screening Business (NASDAQ:GRFS)
finance.yahoo.com - January 31 at 6:09 PM
finance.yahoo.com logoGrifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million (NASDAQ:GRFS)
finance.yahoo.com - January 31 at 6:09 PM
News IconTrading Scope: ADX and CCI Review for Grifols SA (GRFS) - Springdale Times (NASDAQ:GRFS)
springdaletimes.com - January 31 at 4:15 AM
capitalcube.com logoGrifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers : January 30, 2017 (NASDAQ:GRFS)
www.capitalcube.com - January 30 at 6:13 PM
News IconTrading Focus: Checking ATR Levels for Grifols S.A. (GRFS) - Sherwood Daily (NASDAQ:GRFS)
sherwooddaily.com - January 29 at 3:44 AM
realistinvestor.com logoMean Rating Of Grifols, SA (NASDAQ:GRFS) At $2.1 - RealistInvestor.com (NASDAQ:GRFS)
www.realistinvestor.com - January 29 at 3:44 AM
4-traders.com logoGrifols : Research Reports Coverage on Biotech Stocks -- Idera Pharma, Ocular Therapeutix, Radius Health, and Grifols (NASDAQ:GRFS)
www.4-traders.com - January 28 at 1:44 AM
News IconRelative Strength Index Check on Grifols S.A. (GRFS) - Market Point (NASDAQ:GRFS)
mtptnews.com - January 27 at 5:05 AM
News IconRelative Strength Index Check on Grifols SA (GRFS) - Market Point (NASDAQ:GRFS)
mtptnews.com - January 26 at 7:02 PM
News IconEarnings in Full Force, Analysts Take Aim at Grifols, S.A. (NASDAQ:GRFS) - Wall Street Beacon (NASDAQ:GRFS)
wsbeacon.com - January 26 at 7:02 PM
News IconTechnical Level Spotcheck on Shares of Grifols S.A. (GRFS) - Rives Journal (NASDAQ:GRFS)
rivesjournal.com - January 20 at 12:19 AM
News IconGrifols, S.A. (NASDAQ:GRFS) Valuation According To Analysts - UK Market News (NASDAQ:GRFS)
www.ukmarketnews.co.uk - January 19 at 7:17 PM
News IconChart Indicator Check on Shares of Grifols S.A. (GRFS) - Sherwood Daily (NASDAQ:GRFS)
sherwooddaily.com - January 19 at 4:00 AM
News IconTechnical Roundup on Shares of Grifols S.A. (GRFS) - Sherwood Daily (NASDAQ:GRFS)
sherwooddaily.com - January 17 at 3:32 PM
News IconWill The Needle Move For Grifols, S.A. (NASDAQ:GRFS) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:GRFS)
wsbeacon.com - January 12 at 10:57 PM
News IconHigh Market Cap Stock of the Day – Grifols, S.A. (NASDAQ:GRFS) (NASDAQ:GRFS)
twincountynews.com - January 11 at 8:04 AM
News IconImportant Rating: Is Grifols S.A (NASDAQ:GRFS) Worth Your Time After JP Morgan’s Upgrade? (NASDAQ:GRFS)
www.whatsonthorold.com - January 4 at 11:33 PM
marketexclusive.com logoAnalyst Upgrades – Grifols, S.A. (NASDAQ:GRFS) Stock Gets Upgraded By J P Morgan Chase & Co from Neutral to Overweight (NASDAQ:GRFS)
marketexclusive.com - January 3 at 8:04 PM
finance.yahoo.com logoGrifols, S.A. upgraded by JP Morgan (NASDAQ:GRFS)
finance.yahoo.com - January 3 at 8:04 PM
nasdaq.com logoInteresting GRFS Put And Call Options For August 2017 - Nasdaq (NASDAQ:GRFS)
www.nasdaq.com - December 21 at 6:24 PM
nasdaq.com logoInteresting GRFS Put And Call Options For August 2017 (NASDAQ:GRFS)
www.nasdaq.com - December 20 at 10:28 PM
4-traders.com logoGrifols : agreed to acquire Hologic’s share of NAT donor screening unit for USD 1,850 million Download (217.8 Kb) (NASDAQ:GRFS)
www.4-traders.com - December 15 at 6:05 PM
investors.com logoHologic Still A Buy After Getting 'Lofty' Price For Blood-Screening Unit (NASDAQ:GRFS)
www.investors.com - December 15 at 6:05 PM
thestreet.com logoHologic Agrees to Sell Blood Screening Business to Grifols for $1.85B (NASDAQ:GRFS)
www.thestreet.com - December 14 at 11:15 PM
4-traders.com logoGrifols : Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion (NASDAQ:GRFS)
www.4-traders.com - December 14 at 6:13 PM
finance.yahoo.com logoHologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion (NASDAQ:GRFS)
finance.yahoo.com - December 14 at 6:13 PM
finance.yahoo.com logoGrifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million (NASDAQ:GRFS)
finance.yahoo.com - December 14 at 6:13 PM
finance.yahoo.com logo4:30 pm Grifols, S.A. confirms acquisition of Hologic's (HOLX (NASDAQ:GRFS)
finance.yahoo.com - December 14 at 6:13 PM
marketwatch.com logoHologic to sell stake in blood screening unit for $1.85 bln (NASDAQ:GRFS)
www.marketwatch.com - December 14 at 6:13 PM
sg.finance.yahoo.com logoGrifols to buy Hologic's stake in blood screening JV for $1.85 billion (NASDAQ:GRFS)
sg.finance.yahoo.com - December 14 at 6:13 PM
capitalcube.com logoETFs with exposure to Grifols SA : December 13, 2016 (NASDAQ:GRFS)
www.capitalcube.com - December 13 at 6:03 PM
capitalcube.com logoETFs with exposure to Grifols SA : December 2, 2016 (NASDAQ:GRFS)
www.capitalcube.com - December 2 at 5:26 PM
4-traders.com logoGrifols : Research Reports Coverage on Biotech Stocks -- Biogen, BioMarin Pharma, Seattle Genetics, and Grifols (NASDAQ:GRFS)
www.4-traders.com - November 30 at 9:13 AM
News IconMarket Rover: Looking at Levels on Shares of Grifols S.A. (GRFS) - StockTalk Daily (NASDAQ:GRFS)
stocktalkdaily.com - November 22 at 5:07 PM
News IconInvestor Watchlist: Narrowing in on Shares of Grifols S.A. (GRFS) - StockTalk Daily (NASDAQ:GRFS)
stocktalkdaily.com - November 22 at 8:46 AM
News IconTechnical Watch on These Shares: Grifols S.A. (GRFS) - StockTalk Daily (NASDAQ:GRFS)
stocktalkdaily.com - November 18 at 6:54 AM
News IconLatest Analyst Consensus For Grifols, S.A. (NASDAQ:GRFS) - UK Market News (NASDAQ:GRFS)
www.ukmarketnews.co.uk - November 15 at 8:39 AM
capitalcube.com logoGrifols SA :GRFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 (NASDAQ:GRFS)
www.capitalcube.com - November 11 at 4:51 PM
News IconGrifols, S.A. (NASDAQ:GRFS) Analyst Review - NewsDen (NASDAQ:GRFS)
newsden.net - November 11 at 9:34 AM
nasdaq.com logoBullish Two Hundred Day Moving Average Cross - GRFS (NASDAQ:GRFS)
www.nasdaq.com - November 10 at 11:01 PM
News IconInvestment Doubling Stocks on Cards: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Grifols, S.A. (NASDAQ:GRFS) - Street Wise Report (press release) (blog) (NASDAQ:GRFS)
streetwisereport.com - November 10 at 7:32 AM
News IconGrifols, S.A. (NASDAQ:GRFS) has 1 Year Target Estimate of $15 - The Newburgh Press (NASDAQ:GRFS)
newburghpress.com - November 9 at 11:07 PM
publicnow.com logoSales of the Bioscience Division grow by +6.5%, increasing Grifols' revenues to EUR 2,952 million (NASDAQ:GRFS)
www.publicnow.com - November 8 at 8:03 AM
publicnow.com logoSales of the Bioscience Division grow by +6.5%, increasing Grifols’ revenues to EUR 2,952 million Download (377.6 Kb) (NASDAQ:GRFS)
www.publicnow.com - November 8 at 8:03 AM
News IconCurrent Price Targets For Grifols, S.A. (NASDAQ:GRFS) - NewsDen (NASDAQ:GRFS)
newsden.net - November 5 at 9:24 AM
News IconAnalyst Coverage: Grifols, S.A. (NASDAQ:GRFS) - NewsDen (NASDAQ:GRFS)
newsden.net - November 4 at 4:13 PM

Social

What is Grifols, S.A.'s stock symbol?

Grifols, S.A. trades on the NASDAQ under the ticker symbol "GRFS."

How often does Grifols, S.A. pay dividends? What is the dividend yield for Grifols, S.A.?

Grifols, S.A. declared a dividend on Tuesday, November 22nd. Stockholders of record on Wednesday, December 7th will be paid a dividend of $0.153 per share on Wednesday, December 7th. The ex-dividend date is Monday, December 5th. This is a boost from Grifols, S.A.'s previous dividend of $0.11.

When did Grifols, S.A.'s stock split? How did Grifols, S.A.'s stock split work?

Grifols, S.A.'s stock split before market open on Monday, January 4th 2016. The 2-1 split was announced on Thursday, December 3rd 2015. The newly minted shares were distributed to shareholders after the closing bell on Thursday, December 31st 2015. An investor that had 100 shares of Grifols, S.A. stock prior to the split would have 200 shares after the split.

Who owns Grifols, S.A. stock?

Grifols, S.A.'s stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Artisan Partners Limited Partnership (1.01%), FMR LLC (0.30%), FIL Ltd (0.27%), Two Sigma Investments LP (0.06%), Baird Financial Group Inc. (0.06%) and Van ECK Associates Corp (0.05%).

Who sold Grifols, S.A. stock? Who is selling Grifols, S.A. stock?

Grifols, S.A.'s stock was sold by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, Two Sigma Investments LP, Oxford Asset Management, Gamco Investors INC. ET AL, Thornburg Investment Management Inc., Keybank National Association OH, Envestnet Asset Management Inc. and Fiera Capital Corp.

Who bought Grifols, S.A. stock? Who is buying Grifols, S.A. stock?

Grifols, S.A.'s stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, FIL Ltd, FFT Wealth Management LLC, Denver Investment Advisors LLC, Baird Financial Group Inc., Santa Barbara Asset Management LLC, Pacad Investment Ltd. and A.R.T. Advisors LLC.

How do I buy Grifols, S.A. stock?

Shares of Grifols, S.A. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Grifols, S.A. stock cost?

One share of Grifols, S.A. stock can currently be purchased for approximately $17.47.

Grifols, S.A. (NASDAQ:GRFS) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Grifols, S.A. (NASDAQ:GRFS)

Earnings History Chart

Earnings by Quarter for Grifols, S.A. (NASDAQ:GRFS)

Dividend History Chart

Dividend Payments by Quarter for Grifols, S.A. (NASDAQ:GRFS)

Last Updated on 2/22/2017 by MarketBeat.com Staff